BOTHE.BR
Price:
$0.29
Market Cap:
$2.19M
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.[Read more]
Industry
Biotechnology
IPO Date
2015-02-06
Stock Exchange
EURONEXT
Ticker
BOTHE.BR
According to Bone Therapeutics SA’s latest financial reports and current stock price. The company's current Enterprise Value is 30.23M. This represents a change of -23.94% compared to the average of 39.75M of the last 4 quarters.
The mean historical Enterprise Value of Bone Therapeutics SA over the last ten years is 47.48M. The current 30.23M Enterprise Value has changed 6.27% with respect to the historical average. Over the past ten years (40 quarters), BOTHE.BR's Enterprise Value was at its highest in in the September 2022 quarter at 59.69M. The Enterprise Value was at its lowest in in the June 2015 quarter at -27710000.00.
Average
47.48M
Median
39.39M
Minimum
25.48M
Maximum
107.45M
Discovering the peaks and valleys of Bone Therapeutics SA Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.61%
Maximum Annual Enterprise Value = 107.45M
Minimum Annual Increase = -57.72%
Minimum Annual Enterprise Value = 25.48M
Year | Enterprise Value | Change |
---|---|---|
2023 | 36.42M | 19.34% |
2022 | 30.52M | 19.78% |
2021 | 25.48M | -16.81% |
2020 | 30.63M | -23.14% |
2019 | 39.85M | 2.37% |
2018 | 38.93M | -33.49% |
2017 | 58.53M | 28.83% |
2016 | 45.43M | -57.72% |
2015 | 107.45M | 74.61% |
2014 | 61.54M | 18.56% |
The current Enterprise Value of Bone Therapeutics SA (BOTHE.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.81M
5-year avg
32.58M
10-year avg
47.48M
Bone Therapeutics SA’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Therapeutics SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bone Therapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bone Therapeutics SA's Enterprise Value?
What is the highest Enterprise Value for Bone Therapeutics SA (BOTHE.BR)?
What is the 3-year average Enterprise Value for Bone Therapeutics SA (BOTHE.BR)?
What is the 5-year average Enterprise Value for Bone Therapeutics SA (BOTHE.BR)?
How does the current Enterprise Value for Bone Therapeutics SA (BOTHE.BR) compare to its historical average?